Related references
Note: Only part of the references are listed.Insulin resistance: from bit player to centre stage
Gerald M. Reaven
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Vasculotoxic Effects of Insulin and Its Role in Atherosclerosis: What is the Evidence?
Shailesh Nandish et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
A1C and Cardiovascular Outcomes in Type 2 Diabetes A nested case-control study
Danielle C. Colayco et al.
DIABETES CARE (2011)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
Harold E. Lebovitz
DIABETES CARE (2011)
Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes
Stephen S. Johnston et al.
DIABETES CARE (2011)
Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
K. L. Rensing et al.
DIABETES OBESITY & METABOLISM (2011)
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
J. A. Johnson et al.
DIABETOLOGIA (2011)
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
L. G. Mellbin et al.
DIABETOLOGIA (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Excess Exposure to Insulin Is the Primary Cause of Insulin Resistance and its Associated Atherosclerosis
Wenhong Cao et al.
Current Molecular Pharmacology (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
J. -M. Gamble et al.
DIABETES OBESITY & METABOLISM (2010)
Mitogenic action of insulin: friend, foe or 'frenemy'?
B. Draznin
DIABETOLOGIA (2010)
Intensified glucose lowering in type 2 diabetes: time for a reappraisal
J. S. Yudkin et al.
DIABETOLOGIA (2010)
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
S. L. Bowker et al.
DIABETOLOGIA (2010)
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Craig J. Currie et al.
LANCET (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
The proliferating role of insulin and insulin-like growth factors in cancer
Emily Jane Gallagher et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori et al.
ANNALS OF INTERNAL MEDICINE (2009)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus
Valter Donadon et al.
Expert Review of Gastroenterology & Hepatology (2009)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart
Matteo Anselmino et al.
EUROPEAN HEART JOURNAL (2008)
Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
Furong Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Insulin-treated dia betes is associated with a marked increase in mortality in patients with advanced heart failure
S Smooke et al.
AMERICAN HEART JOURNAL (2005)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy
L Bonelli et al.
PANCREAS (2003)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Share Paper
